Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ofra Maimon

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Medical Oncology (Northwood, London, England)|April 24, 2013
TL-118-anti-angiogenic treatment in pancreatic cancer: a case reportShani Breuer, Ofra Maimon, Liat Appelbaum, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 4, 2025
Remote group intervention for adults with cancer-related cognitive impairment: a feasibility studyChenanit Hamami, Tamar Peretz, Mor Nahum, et al.
Seminars in Cancer Biology|September 22, 2023
Excess body weight and postmenopausal breast cancer: Emerging molecular mechanisms and perspectivesDaniela Nahmias-Blank, Ofra Maimon, Amichay Meirovitz, et al.
Anticancer Research|December 26, 2012
The prognostic significance of LIAISON(R) CA15-3 assay in primary breast cancerBenjamin Nisman, Ofra Maimon, Tanir Allweis, et al.
Journal of the Endocrine Society|August 11, 2022
Prognostic Factors in Advanced Adrenocortical Carcinoma: Summary of a National Referral Center's 20 years of ExperienceJohnathan Arnon, Simona Grozinsky-Glasberg, Kira Oleinikov, et al.
Anticancer Research|December 31, 2021
Thyroid Hormones and Morphological Features of Primary Breast CancerAmichay Meirovitz, Benjamin Nisman, Tanir M Allweis, et al.
Anticancer Research|January 31, 2021
Elevated Free Triiodothyronine Is Associated With Increased Proliferative Activity in Triple-negative Breast CancerBenjamin Nisman, Tanir M Allweis, Einat Carmon, et al.
Anticancer Research|October 28, 2020
Thyroid Hormones, Silencing Mediator for Retinoid and Thyroid Receptors and Prognosis in Primary Breast CancerBenjamin Nisman, Tanir M Allweis, Einat Carmon, et al.
Frontiers in Oncology|August 14, 2024
Improving the response to lenvatinib in partial responders using a Constrained-Disorder-Principle-based second-generation artificial intelligence-therapeutic regimen: a proof-of-concept open-labeled clinical trialTal Sigawi, Ram Gelman, Ofra Maimon, et al.
Biomedicines|August 28, 2025
Unraveling the Role of Metabolic Endotoxemia in Accelerating Breast Tumor ProgressionDaniela Nahmias Blank, Ofra Maimon, Esther Hermano, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Medical Oncology (Northwood, London, England)|April 24, 2013
TL-118-anti-angiogenic treatment in pancreatic cancer: a case reportShani Breuer, Ofra Maimon, Liat Appelbaum, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 4, 2025
Remote group intervention for adults with cancer-related cognitive impairment: a feasibility studyChenanit Hamami, Tamar Peretz, Mor Nahum, et al.
Seminars in Cancer Biology|September 22, 2023
Excess body weight and postmenopausal breast cancer: Emerging molecular mechanisms and perspectivesDaniela Nahmias-Blank, Ofra Maimon, Amichay Meirovitz, et al.
Anticancer Research|December 26, 2012
The prognostic significance of LIAISON(R) CA15-3 assay in primary breast cancerBenjamin Nisman, Ofra Maimon, Tanir Allweis, et al.
Journal of the Endocrine Society|August 11, 2022
Prognostic Factors in Advanced Adrenocortical Carcinoma: Summary of a National Referral Center's 20 years of ExperienceJohnathan Arnon, Simona Grozinsky-Glasberg, Kira Oleinikov, et al.
Anticancer Research|December 31, 2021
Thyroid Hormones and Morphological Features of Primary Breast CancerAmichay Meirovitz, Benjamin Nisman, Tanir M Allweis, et al.
Anticancer Research|January 31, 2021
Elevated Free Triiodothyronine Is Associated With Increased Proliferative Activity in Triple-negative Breast CancerBenjamin Nisman, Tanir M Allweis, Einat Carmon, et al.
Anticancer Research|October 28, 2020
Thyroid Hormones, Silencing Mediator for Retinoid and Thyroid Receptors and Prognosis in Primary Breast CancerBenjamin Nisman, Tanir M Allweis, Einat Carmon, et al.
Frontiers in Oncology|August 14, 2024
Improving the response to lenvatinib in partial responders using a Constrained-Disorder-Principle-based second-generation artificial intelligence-therapeutic regimen: a proof-of-concept open-labeled clinical trialTal Sigawi, Ram Gelman, Ofra Maimon, et al.
Biomedicines|August 28, 2025
Unraveling the Role of Metabolic Endotoxemia in Accelerating Breast Tumor ProgressionDaniela Nahmias Blank, Ofra Maimon, Esther Hermano, et al.
Pageof 3